Back to search
FDAFDA · Food and drugs·Recall number Z-2646-2026

RayCare 2024A SP1. Oncology Information Systems.

Published July 8, 2026 · Recall initiated: May 20, 2026

Summary

FDA records medical device Class II recall Z-2646-2026, published July 8, 2026 and initiated May 20, 2026. Recalling firm: RAYSEARCH LABORATORIES AB; Status: Ongoing; Reported quantity: 3 units; Lot: Software Version 8.0.1.60193, UDI 0735000201083920240906, Expiration Date: 2030-01-24. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Beam set delivery note issues in which there is potential data loss if the beam set delivery note is modified simultaneously and/or if a note is updated during a treatment session, the user is not notified of the change.

What to do

Voluntary: Firm initiated

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
RAYSEARCH LABORATORIES AB
Distributor
Worldwide - US Nationwide distribution.
Lot
Software Version 8.0.1.60193, UDI 0735000201083920240906, Expiration Date: 2030-01-24
Risk classification
Class II
Area (FDA)
device
Country
Sweden

Related recalls

Questions about this recall

Was RayCare 2024A SP1. Oncology Information Systems. recalled?

Yes. FDA published recall Z-2646-2026 on July 8, 2026. Reported hazard: Beam set delivery note issues in which there is potential data loss if the beam set delivery note is modified simultaneously and/or if a note is updated during a treatment session, the user is not notified of the change.

What should I do if I have this product?

Voluntary: Firm initiated